Cell and gene therapy approvals in Asia: regulatory landscape, access and affordability.

Hwang WYK, Bari S, Kawamata S, Choi B, Koaykul C, Huang H, Gupta P

Open source

DOI
10.1016/j.jcyt.2025.08.005
Published
2025 Dec
Container
Cytotherapy
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jcyt.2025.08.005,
  title = {Cell and gene therapy approvals in Asia: regulatory landscape, access and affordability.},
  author = {Hwang WYK and Bari S and Kawamata S and Choi B and Koaykul C and Huang H and Gupta P},
  year = {2025},
  journal = {Cytotherapy},
  doi = {10.1016/j.jcyt.2025.08.005},
  url = {https://doi.org/10.1016/j.jcyt.2025.08.005}
}

RIS

TY  - JOUR
TI  - Cell and gene therapy approvals in Asia: regulatory landscape, access and affordability.
AU  - Hwang WYK
AU  - Bari S
AU  - Kawamata S
AU  - Choi B
AU  - Koaykul C
AU  - Huang H
AU  - Gupta P
PY  - 2025
JO  - Cytotherapy
DO  - 10.1016/j.jcyt.2025.08.005
UR  - https://doi.org/10.1016/j.jcyt.2025.08.005
ER  - 

APA

WYK, H., S, B., S, K., B, C., C, K., H, H., & P, G. (2025). Cell and gene therapy approvals in Asia: regulatory landscape, access and affordability.. Cytotherapy. https://doi.org/10.1016/j.jcyt.2025.08.005

Source records